A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on Padsevonil

Stopped Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures

Conditions

• Healthy Participants
• Epilepsy

Interventions

• DRUG: Padsevonil type 1 Tablet 200 mg
• DRUG: Padsevonil type 2 Tablet
• DRUG: Padsevonil type 3 Tablet
• DRUG: Padsevonil type 4 Tablet
• DRUG: Padsevonil type 5 Tablet

Sponsor

UCB Biopharma SRL